Cartesian Therapeutics, Inc. (RNAC) stock
RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.08−0.27 (-4.25%)
Close on Nov 16, 2026Market cap $183.95MP/E –Yield –
Cartesian Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cartesian Therapeutics's total debt was $52.85M at Jun 30, 2026. For fiscal 2025 it was $0.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $52.85M | – |
| Q4 FY2025 | Dec 31, 2025 | $0 | – |
See a number that looks wrong?